STI screening is routine testing for sexually transmitted infections in people who feel perfectly fine and have no symptoms. That distinction matters: screening checks for infections you don’t know you have, while diagnostic testing investigates a specific symptom like unusual discharge or sores. The reason screening exists is that most STIs cause no obvious signs, especially early on. Between 70% and 80% of women and up to 50% of men with chlamydia never develop symptoms, and up to half of women with gonorrhea don’t either. Without screening, these infections silently spread and can cause serious long-term damage.
Why Screening Matters Without Symptoms
The core problem screening solves is that you can carry and transmit an infection for weeks, months, or even years without knowing it. Chlamydia and gonorrhea, left untreated, can lead to pelvic inflammatory disease, chronic pain, and infertility. Syphilis progresses through stages that can eventually affect the heart and brain. HIV gradually destroys the immune system over years if unmanaged. None of these infections announce themselves reliably in their early, most treatable stages.
The World Health Organization estimates roughly 376 million new treatable STIs occur globally each year among adults aged 15 to 49. That figure includes 127 million cases of chlamydia, 87 million of gonorrhea, and 156 million of trichomoniasis. The vast majority of people with these infections have no idea they’re carrying them. Screening is the only way to catch what symptoms won’t reveal.
What Infections Are Typically Included
There’s no single universal STI panel. What you’re screened for depends on your age, sex, sexual history, and risk factors. The most commonly screened infections are:
- Chlamydia and gonorrhea: Recommended annually for all sexually active women under 25, and for older women with risk factors like new or multiple partners.
- HIV: Recommended at least once for everyone aged 13 to 64, with more frequent screening for higher-risk individuals.
- Syphilis: Recommended for pregnant individuals, men who have sex with men, people living with HIV, and others at increased risk based on factors like geography or sexual history.
- Hepatitis B and C: Often included based on age group or risk factors like injection drug use.
Herpes (HSV-2) is notably not part of routine screening. The CDC does not recommend blood testing for herpes in people without symptoms, even during pregnancy. Herpes testing is reserved for people who have genital symptoms or whose partners have a known diagnosis.
What the Process Looks Like
STI screening is simpler than most people expect. For chlamydia and gonorrhea, the standard method uses a urine sample from men or a vaginal swab from women. If your sexual history includes oral or anal sex, your provider may also recommend swabs of the throat and rectum. These are often self-collected in a private area of the clinic after a provider explains the process.
Syphilis, HIV, and hepatitis screening require blood samples. In a clinical setting, that typically means a standard blood draw from your arm. Rapid tests also exist: HIV can be screened with an oral cheek swab, and syphilis has a rapid finger-prick option. These rapid versions give results in minutes rather than days, though they may be slightly less sensitive than lab-based blood tests.
For lab-processed results, expect a turnaround time of roughly 5 to 10 days. Some clinics will call you only if results are positive, while others provide all results through a patient portal or follow-up visit.
Timing: When Screening Is Accurate
Testing too soon after a potential exposure can produce a false negative because the infection hasn’t built up enough to detect. Each infection has a “window period,” the minimum time between exposure and reliable detection:
- Gonorrhea and chlamydia: Detectable within 1 week in most cases, with 2 weeks catching nearly all infections.
- Syphilis: A blood test catches most cases at 1 month, with 3 months needed to detect almost all.
- HIV (blood antigen/antibody test): Detectable in most people at 2 weeks, with 6 weeks catching almost all. An oral swab test takes longer: 1 month for most, 3 months for near-complete accuracy.
- Hepatitis C: 2 months catches most cases, 6 months catches almost all.
If you’re screening after a specific exposure you’re concerned about, these windows tell you when to schedule your appointment. For routine annual screening with no particular incident in mind, timing is less critical.
At-Home Screening Options
Home-based screening has expanded significantly. There are two main models. In one, a telemedicine provider orders a test kit mailed to your home. You collect the specimen yourself, whether that’s a vaginal swab, urine sample, or finger-prick blood collection, and mail it back to a lab. Results come through the provider’s platform.
The other option is a true self-test you perform and read entirely at home. The FDA authorized the first home test for chlamydia, gonorrhea, and trichomoniasis (the Visby Medical test) for people with vaginas. Its accuracy is high: it correctly identified 97.2% of positive chlamydia samples, 100% of positive gonorrhea samples, and 97.8% of positive trichomoniasis samples. It also correctly identified negatives more than 98.5% of the time across all three infections. A negative result on any home test doesn’t rule out infection entirely, particularly if you have symptoms or a recent known exposure.
Screening During Pregnancy
Prenatal STI screening is a standard part of early pregnancy care. Untreated infections during pregnancy can cause miscarriage, preterm birth, low birth weight, and serious complications for the newborn. Syphilis passed to a baby during pregnancy (congenital syphilis) has been rising sharply in recent years and can be fatal.
Pregnant individuals are typically screened for HIV, syphilis, hepatitis B, chlamydia, and gonorrhea at the first prenatal visit. Those with ongoing risk factors are often rescreened in the third trimester. Herpes blood testing is not recommended during pregnancy unless symptoms are present.
Cost and Insurance Coverage
Under the Affordable Care Act, most health insurance plans must cover preventive STI screening with no out-of-pocket cost to you, as long as the screening has an A or B rating from the U.S. Preventive Services Task Force. This includes chlamydia screening for sexually active women under 25 and HIV screening for adolescents and adults, among others. You should not receive a copay or coinsurance bill for these covered preventive screens.
If you’re uninsured, options still exist. STI clinics run by local health departments, federally qualified health centers, and family planning organizations like Planned Parenthood offer free or low-cost screening. Many of these clinics operate on a sliding fee scale based on income. Financial barriers remain a real obstacle for some people, particularly those who are low income or face issues related to immigration status, but the safety net of publicly funded clinics is specifically designed to fill that gap.
How Often to Get Screened
Screening frequency depends on your individual situation. Sexually active women under 25 are recommended for annual chlamydia and gonorrhea screening. Men who have sex with men are recommended for annual screening for syphilis, HIV, chlamydia, and gonorrhea, with every-3-to-6-month screening for those with multiple partners or who use pre-exposure prophylaxis for HIV. Anyone with a new sexual partner, multiple partners, or a partner who has tested positive for an STI has reason to screen more frequently.
For people in long-term mutually monogamous relationships who have both been tested, ongoing routine screening is generally unnecessary. But any change in circumstances, whether a new partner, a partner’s new diagnosis, or a break in monogamy, resets the clock. Screening is most useful when it’s treated as a regular, unremarkable part of sexual health rather than something reserved for moments of worry.